Drug Search Results
More Filters [+]

Aceneuramic acid

Alternative Names: aceneuramic acid
Latest Update: 2023-10-01
Latest Update Note: PubMed Publication

Product Description

Aceneuramic acid is an N-acetylneuraminic acid that is keto-neuraminic acid in which one of the hydrogens of the amino group is replaced by an acetyl group. It is a member of N-acetylneuraminic acids, a member of acetamides and a 2-oxo monocarboxylic acid. It derives from a keto-neuraminic acid. It is a conjugate acid of an aceneuramate.

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Saudi Arabia

Approved Indications: None

Known Adverse Events: None

Company: Ultragenyx
Company Location: NOVATO CA 94949
Company CEO: Emil D. Kakkis
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Aceneuramic acid

Countries in Clinic: Japan

Active Clinical Trial Count: 1

Highest Development Phases

Phase 3: Distal Myopathies|GNE Myopathy

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

NPC-09-1

P3

Completed

GNE Myopathy|Distal Myopathies

2022-03-29

85%

NPC-09-1

P3

Completed

GNE Myopathy|Distal Myopathies

2022-03-29

85%

Recent News Events